Protalix BioTherapeutics (PLX) Net Margin (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) Net Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,529.00 |
| Mar 31, 2026 | 9,377.00 |
| Dec 31, 2025 | -5,281.00 |
| Sep 30, 2025 | 1,100.00 |
| Jun 30, 2025 | 3,831.00 |
| Mar 31, 2025 | -9,510.00 |
| Dec 31, 2024 | 3,998.00 |
| Sep 30, 2024 | 3,568.00 |
| Jun 30, 2024 | 10,625.00 |
| Mar 31, 2024 | 6,931.00 |
| Dec 31, 2023 | -17,401.00 |
| Sep 30, 2023 | -6,411.00 |
| Jun 30, 2023 | 7,887.00 |
| Mar 31, 2023 | 460.00 |
| Dec 31, 2022 | -1,210.00 |
| Sep 30, 2022 | 3,579.00 |
| Jun 30, 2022 | -4,673.00 |
| Mar 31, 2022 | 6,315.00 |
| Dec 31, 2021 | -4,173.00 |
| Sep 30, 2021 | 14,126.00 |